ACKERMANN CHRISTINA 4
4 · Verona Pharma plc · Filed Apr 30, 2024
Insider Transaction Report
Form 4
ACKERMANN CHRISTINA
Director
Transactions
- Award
Share Options (Right to Buy)
2024-04-29+240,000→ 240,000 totalExercise: $1.93Exp: 2034-04-28→ Ordinary Shares (240,000 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The option vests and becomes exercisable as to 25% on each of July 29, 2024, October 29, 2024, January 29, 2025 and April 29, 2025.